Volume 10,Issue 3
The Role of Gut Microbiota in Ischemic Stroke and Its Traditional Chinese Medicine Intervention
Ischemic stroke (IS) ranks among the leading causes of disability and mortality worldwide, imposing a significant burden upon society and families. Neuroprotection following ischemic stroke constitutes a vital therapeutic approach. In recent years, an increasing body of research has demonstrated that the gut microbiota and its regulation through traditional Chinese medicine may exert neuroprotective effects. This paper systematically reviews relevant studies, delving into the pathways and mechanisms by which traditional Chinese medicine counteracts cerebral ischaemic injury through modulating gut microbiota composition and metabolic functions. It aims to provide novel insights and theoretical foundations for the prevention and treatment of ischaemic stroke.
[1] Yin X, Li S, Wang J, 2025, Research progress of active compounds from traditional chinese medicine in the treatment of stroke. European Journal of Medicinal Chemistry, 291: 117599.
[2] Ren Y, Chen G, Hong Y, 2025, Novel insight into the modulatory effect of traditional chinese medicine on cerebral ischemia-reperfusion injury by targeting gut microbiota: a review. Drug Design Development and Therapy, 19: 185-200.
[3] He Q, Zhou T, He Q, 2025, Targeting CX3CR1 signaling dynamics: a critical determinant in the temporal regulation of post-stroke neurorepair. Brain Sciences, 15(7): 759.
[4] Chen R, Wu P, Cai Z, 2019, Puerariae lobatae radix with chuanxiong rhizoma for treatment of cerebral ischemic stroke by remodeling gut microbiota to regulate the brain-gut barriers. Journal of Nutritional Biochemistry, 65: 101-114.
[5] Silva Y P, Bernardi A, Frozza R L, 2020, The role of short-chain fatty acids from gut microbiota in gut-brain communication. Frontiers in endocrinology, 11: 25.
[6] Kim Y S, Kim J J, Cho K H, 2008, Biotransformation of ginsenoside Rb1, crocin, amygdalin, geniposide, puerarin, ginsenoside Re, hesperidin, poncirin, glycyrrhizin, and baicalin by human fecal microflora and its relation to cytotoxicity against tumor cells. Journal of Microbiology and Biotechnology, 18(6): 1109-1114.
[7] Trinh H T, Joh E H, Kwak H Y, 2010, Anti-pruritic effect of baicalin and its metabolites, baicalein and oroxylin a, in mice. Acta Pharmacologica Sinica, 31(6): 718-724.
[8] Chen R, Wu P, Cai Z, 2019, Puerariae lobatae radix with chuanxiong rhizoma for treatment of cerebral ischemic stroke by remodeling gut microbiota to regulate the brain-gut barriers. Journal of Nutritional Biochemistry, 65: 101-114.
[9] Ding X, Liu Z, Liu Y, 2022, Comprehensive evaluation of the mechanism of Gastrodia elata Blume in ameliorating cerebral ischemia-reperfusion injury based on integrating fecal metabonomics and 16S rDNA sequencing. Frontiers in Cellular and Infection Microbiology, 12: 1026627.
[10] Gao Q, Han Z Y, Tian D F, 2021, Xinglou chengqi decoction improves neurological function in experimental stroke mice as evidenced by gut microbiota analysis and network pharmacology. Chinese Journal of Natural Medicines, 19(12): 881-899.
[11] Zhang F, Zhai M, Wu Q, 2020, Protective Effect of Tong-Qiao-Huo-Xue Decoction on Inflammatory Injury Caused by Intestinal Microbial Disorders in Stroke Rats. Biological & Pharmaceutical Bulletin, 43(5): 788-800.
[12] Zhang H, Hui X, Wang Y, 2022, Angong niuhuang pill ameliorates cerebral ischemia/reperfusion injury in mice partly by restoring gut microbiota dysbiosis. Frontiers in Pharmacology, 13: 1001422.